For research use only
| Cat No. | ABC-TC3921 |
| Product Type | Mouse Primary Cells |
| Cell Type | Neuron |
| Species | C57 Mouse |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Brain |
| Disease | Normal |
| Storage | Liquid Nitrogen |
C57 Mouse Striatum Neuron suspensions prepared from embryonic brain provide high-quality primary neuronal cells, including glia, for neuroscience studies.
C57 Mouse Striatum Neurons are primary cells isolated from the striatal tissue of C57BL/6 mice. As primary neuronal cells, they are terminally differentiated and display a characteristic multipolar morphology with elaborate dendritic arbors and axonal projections essential for basal ganglia circuitry. These cells require coated surfaces for adherent growth. Functionally, these terminally differentiated neurons play important roles in motor control and cognitive functions. Dysfunction of striatal neurons has been implicated in neurodegenerative disorders such as Parkinson’s disease and Huntington’s disease. Karyotype analysis reveals normal diploidy. Each lot undergoes rigorous screening and isolation procedures, and is rigorously tested to ensure it is free of contamination from Mycoplasma, Fungi, Yeast, and Bacteria.
| Product Code | C57 Mouse Striatum Neurons, C57BL/6 Striatal Neurons, C57 Striatum Neuron Cells, Murine C57 Striatal Neurons |
| Species | C57 Mouse |
| Cat.No | ABC-TC3921 |
| Product Category | Primary Cells |
| Size/Quantity | 1 vial |
| Cell Type | Neuron |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Brain |
| Disease | Normal |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Mouse Primary Cells |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
C57 Mouse Striatum Neurons can be used as an in vitro cell model to study the pathogenesis of movement disorders and neurodegenerative diseases, such as Huntington’s and Parkinson’s diseases. Researchers can utilize these authentic striatal neurons to investigate their vulnerability to excitotoxicity, dopamine-mediated signaling, and response to mutant huntingtin proteins, thereby exploring molecular pathways underlying striatal dysfunction. This supports discovery research and molecular target identification related to movement-associated neurological disorders associated with aberrant striatal neuronal physiology in motor control and pathological dysregulation in disease.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).